"While we are disappointed by the Court's decision to uphold this ruling, we intend to continue our strong efforts to convey the significant benefits of NAMENDA XR@ to physicians, patients and caregivers," said Brent Saunders, CEO and President of Actavis.
Thousands of defendants convicted of drug crimes after a chemist in a state lab tampered with...
Three years ago a jury found that a subsidiary, Janssen Pharmaceutical, committed Medicaid fraud...
Pfizer Inc. today announced that it has received a request for additional information from the...
U.S. District Court Judge Charles Breyer said the acts alleged by prosecutors do not fall under an exemption in federal drug law for transportation companies such as FedEx.
Steps are being taken to resume executions in a state that hasn't imposed the death penalty since 1997.
Colombian President Santos last week decided to halt fumigation in the wake of a report by a research arm of the World Health Organization classifying (anti-coca) glyphosate as a probable carcinogen.
Thirteen percent of drugs marketed in the United States today post pharmacogenomic information on the label, but developers continue to encounter compliance challenges.
Attorneys for FedEx are set to appear in court, as they seek to dismiss a federal indictment that accuses the company of knowingly shipping illegal prescription drugs from two online pharmacies.
How pharmaceutical legal departments can create a competitive advantage for the enterprise.
ProPharma Group, a compliance services company, today announced its acquisition of PROSAR, a provider of pharmacovigilance and medical information services.
State senators, for a second time, have sent legislation legalizing medical marijuana to the House of Representatives, where the GOP majority has held hearings but given no certain signs of support.
ANI Pharmaceuticals has acquired the approved new drug application ("NDA") for a testosterone gel 1% product previously licensed to Teva Pharmaceuticals.
If the Supreme Court rules the way most Republicans want in the latest health overhaul case, GOP lawmakers who now have insurance coverage under President Barack Obama's law may wind up with some explaining to do.
Federal health advisers recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients.
The FDA has granted Fast Track Designation for cobiprostone, a locally acting chloride channel activator for the prevention of oral mucositis.
The California Supreme Court ruled that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash payments.
The Food and Drug Administration said in an online review that the benefit was small and it is unclear if the addition of a second drug ingredient adds to the pill's effectiveness.
A huge nationwide spike in hospitalizations last month was caused by a class of drugs often called synthetic marijuana, possibly illustrating the potency and dangers of the chemicals used to make them.
Mylan N.V. today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, which is the generic version of Teva's Seasonale Tablets.
Now drug giant Johnson & Johnson is taking an unusual step, turning to independent bioethicists for advice.
Teva announced a voluntary recall of eight lots of Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter.
This year, many Afghan poppy farmers are expecting a windfall as they get ready to harvest opium from a new variety of poppy seeds said to boost yield of the resin that produces heroin.
Connecticut police say they are investigating a batch of tainted synthetic marijuana that has sent about a dozen people to the hospital.
Dow Development Laboratories in California is working to position itself as the "go-to" contract manufacturer for topical product development services.
The FDA today approved Raplixa, the first spray-dried fibrin sealant approved by the agency. It is used to help control bleeding during surgery.
Tuzistra XR is an extended-release oral suspension combination of codeine and chlorpheniramine in treating coughs and upper respiratory allergies.
The GOP-controlled House barely rejected a bid by supporters of medical marijuana that would have permitted veterans to receive information about the drug from their government doctors.
The Pharmaceutical Research and Manufacturers of America (PhRMA) today released statements in that were critical of bills in the House and Senate aimed at curbing abusive patent litigation.
- Page 1